An MHealth Intervention to Improve HIV Prevention Service Engagement Among Racially Diverse Women Who Use Drugs
LOTUS
LOTUS: an MHealth Intervention to Improve HIV Prevention Service Engagement Intersectional Stigma Among Racially and Ethnically Diverse Women Who Use Drugs
2 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this pilot randomized controlled trial is to assess the feasibility, acceptability, and preliminary impact of the mHeaLth interventiOn To redUce Stigma (LOTUS) intervention to improve HIV prevention service engagement and reduce intersectional stigma among racially diverse women who use drugs. LOTUS is a technology-delivered intervention that provides HIV prevention informational content and tips, peer social support and social networking features, a resource locator, HIV prevention monitoring and reminders (e.g., reminders for HIV/STI testing and PrEP doses), and virtual guided discussions with health care professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 5, 2023
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
March 4, 2025
February 1, 2025
1.1 years
September 19, 2023
February 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
LOTUS Feasibility
The feasibility of the LOTUS mHealth intervention will be measured by participant retention and via intervention use data.
6 months
LOTUS Acceptability
The acceptability of the LOTUS mHealth intervention will be measured via the System Usability Scale (SUS), with possible scores ranging from 10-50 and higher scores indicating higher acceptability.
6 months
HIV Prevention Service Engagement
The percentage of participants who report obtaining an HIV/STI test and/or initiating PrEP
6 months
Secondary Outcomes (1)
Stigma
6 months
Study Arms (2)
LOTUS Intervention Arm
EXPERIMENTALA mobile, WebApp-based platform to access the LOTUS intervention content.
Informational Control Arm
ACTIVE COMPARATORAn information-only website, with content on HIV transmission, PrEP, harm reduction, and resources for women.
Interventions
A mobile, WebApp-based intervention comprised of tips for HIV prevention, a community wall for peer interaction and support, HIV prevention monitoring and reminders, guided discussions with a health care professional, a resource database, and a personalized profile. Intervention components are designed to promote HIV prevention service use, reduce stigma and improve social support, coping strategies, and positive affect.
Access to an information-only website with content on HIV transmission, PrEP, harm reduction, and resources for women.
Eligibility Criteria
You may qualify if:
- years of age or older
- Current female identity
- Assigned female at birth
- Report weekly or daily use of opioids and/or stimulants in the past 6 months
- Meet current CDC eligibility criteria for PrEP
- Report low levels of HIV prevention service engagement in the past 6 months
- Not currently, or planning on becoming, pregnant during the study
- Owns a smartphone with internet web-browsing capabilities
You may not qualify if:
- years of age or younger
- Current gender identity other than female
- Not assigned female at birth
- Does not report weekly or daily use of opioids and/or stimulants in the past 6 months
- Does not meet current CDC eligibility criteria for PrEP
- Report high levels of HIV prevention service engagement in the past 6 months
- Currently, or planning on becoming, pregnant during the study
- Does not own a smartphone with internet web-browsing capabilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Diego
La Jolla, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 19, 2023
First Posted
October 5, 2023
Study Start
June 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
March 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share